Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yun Zhang
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0009-0007-0122-3977
Observed ORCID:
0009-0007-0122-3977
OpenAlex ID:
A5137598012
A clinically applicable AI system for detection and diagnosis of bone metastases using CT scans
2025
·
Yun Zhang
, Jiao Li
, et al.
·
Nature Communications
·
30
PDF
Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
·
Clinical Cancer Research
·
4
Supplementary Data S1 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Figure S3 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Data from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Table S2 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Table S3 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Figure S2 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Figure S1 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Table S1 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Show more works
View as search
Works count:
10
Citation count:
34
H-index:
2
I10-index:
1
Year
Topic
Type